Page last updated: 2024-10-16

gamma-aminobutyric acid and Optic Nerve Diseases

gamma-aminobutyric acid has been researched along with Optic Nerve Diseases in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crofts, K1
Brennan, R1
Kearney, P1
O'Connor, G1

Other Studies

1 other study available for gamma-aminobutyric acid and Optic Nerve Diseases

ArticleYear
Vigabatrin-induced optic neuropathy.
    Journal of neurology, 1997, Volume: 244, Issue:10

    Topics: Anticonvulsants; Child; Female; gamma-Aminobutyric Acid; Humans; Optic Nerve Diseases; Vigabatrin

1997